NCT00104260View on ClinicalTrials.gov

Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria

PHASE2CompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

November 30, 2005

Conditions
Phenylketonurias
Interventions
DRUG

sapropterin dihydrochloride

Trial Locations (13)

Unknown

Los Angeles

Oakland

New Haven

Chicago

Boston

Minneapolis

St Louis

New York

Portland

Pittsburgh

Dallas

Salt Lake City

Madison

Sponsors
All Listed Sponsors
lead

BioMarin Pharmaceutical

INDUSTRY